RETRACTED: Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines
- 25 March 2009
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 281 (2), 196-202
- https://doi.org/10.1016/j.canlet.2009.02.045
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic AcidClinical Cancer Research, 2008
- Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive PhenotypeCancer Research, 2008
- Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinomaInvestigational New Drugs, 2006
- Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathwaysAnti-Cancer Drugs, 2006
- Intravesical gemcitabine: an update of clinical resultsCurrent Opinion in Urology, 2006
- Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivoCancer Research, 2006
- Inhibition of Hepatocellular Carcinomas in vitro and Hepatic Metastases in vivo in Mice by the Histone Deacetylase Inhibitor HA-ButClinical Cancer Research, 2004
- Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentialsBiochemical and Biophysical Research Communications, 2004
- Phenylbutyrate inhibits the invasive properties of prostate and breast cancer cell lines in the sea urchin embryo basement membrane invasion assayInternational Journal of Cancer, 2002
- Oxalate Selectively Activates p38 Mitogen-activated Protein Kinase and c-Jun N-terminal Kinase Signal Transduction Pathways in Renal Epithelial CellsPublished by Elsevier BV ,2002